Clinical Trial Update: PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study) [Phase 4]

View source ↗

Summary

Phase 4 POTENT trial evaluating povidone-iodine to prevent Staphylococcus aureus surgical site infections after fixation of HELEF; the study is active but not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Surgical Site Infection

Drugs mentioned

• Povidone-iodine (povidone-iodine)

Snippet

Sponsor: Loreen Herwaldt | Conditions: Surgical Site Infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING